Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial.

Ignazio Carreca, Gianluca D'Aiuto, Luciana De Luca

Research output: Contribution to conferenceOther

Original languageEnglish
Pages170-170
Publication statusPublished - 2007

Cite this

@conference{198152ff89d443c39e4a41e457a361a2,
title = "Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial.",
author = "Ignazio Carreca and Gianluca D'Aiuto and {De Luca}, Luciana",
year = "2007",
language = "English",
pages = "170--170",

}

TY - CONF

T1 - Weekly cisplatin-epirubicin-paclitaxel vs. dose-dense cisplatin-epirubicin-vinorelbine in locally advanced breast cancer: Interim analysis of the SICOG 0302 phase III trial.

AU - Carreca, Ignazio

AU - D'Aiuto, Gianluca

AU - De Luca, Luciana

PY - 2007

Y1 - 2007

UR - http://hdl.handle.net/10447/4411

M3 - Other

SP - 170

EP - 170

ER -